跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
STERISPORIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
STERISPORIN
Authorized
STANDARD
STERISPORIN
steri-med pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a93176c9df5af90c
Company
steri-med pharma inc.
Type
Standard
Approval Details
Approval Id
a93176c9df5af90c
Drug Approval Canada Name
STERISPORIN
Product Name
STERISPORIN
Status
Marketed
Status Date
2021-06-03
Original Market Date
2017-05-31
Din
02359928
Drug Class
Human
Dosage Form
Ointment
Route Of Administration
Ophthalmic
Schedule
OTC
Ahfs
52:04.04
Atc Original
S01AA30 COMBINATIONS OF DIFFERENT ANTIBIOTICS
Atc Name
s 01 aa 30
Aig Number
0231324002
Company Name
steri-med pharma inc.
Company Address
242, Rue Saint-Cyrille Ouest, Upton, Quebec, Canada, J0H 2E0
Active Ingredients
BACITRACIN ZINC
500 UNIT / G
POLYMYXIN B SULFATE
10000 UNIT / G
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a93176c9df5af90c
Type
Standard
Back to Health Canada Approvals